Cytosorbents's market cap is currently ―. The company's EPS TTM is $-0.753; its P/E ratio is -4.41; Cytosorbents is scheduled to report earnings on May 9, 2023, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 7.64M	$ 6.46M	$ 7.33M	$ 7.92M	$ 7.73M
Gross Profit	$ 4.01M	$ 1.97M	$ 3.78M	$ 5.65M	$ 4.60M
EBIT	$ -6.36M	$ -9.02M	$ -8.36M	$ -7.79M	$ -9.56M
EBITDA	$ -6.08M	$ -8.74M	$ -8.06M	$ -7.51M	$ -8.95M
Net Income Common Stockholders	$ -766.13K	$ -12.20M	$ -10.88M	$ -8.97M	$ -9.31M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 22.14M	$ 22.55M	$ 30.16M	$ 43.02M	$ 52.14M
Total Assets	$ 63.23M	$ 62.27M	$ 71.21M	$ 83.27M	$ 89.52M
Total Debt	$ 18.25M	$ 13.39M	$ 13.51M	$ 13.66M	$ 13.82M
Net Debt	$ -3.89M	$ -9.17M	$ -16.66M	$ -29.36M	$ -38.32M
Total Liabilities	$ 27.86M	$ 23.13M	$ 23.65M	$ 27.84M	$ 26.94M
Stockholders Equity	$ 35.37M	$ 39.14M	$ 47.56M	$ 55.43M	$ 62.58M
Cash Flow	-
Free Cash Flow	$ -5.55M	$ -7.45M	$ -12.72M	$ -8.97M	$ -7.16M
Operating Cash Flow	$ -5.34M	$ -6.73M	$ -8.04M	$ -8.12M	$ -5.49M
Investing Cash Flow	$ -206.08K	$ -716.53K	$ -4.69M	$ -847.96K	$ -1.67M
Financing Cash Flow	$ 5.00M	$ 0.00	$ 0.00	$ -40.36K	$ -80.92K

Currency in USD

Cytosorbents Earnings and Revenue History

Income Statement >

Cytosorbents Debt to Assets

Balance Sheet >

Cytosorbents Cash Flow

Cash Flow >

Cytosorbents Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing